We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results:1-10 of 177

OIG Provides Strong Rebuke of Pharmaceutical Free Drug Program
  • Cooley LLP
  • USA
  • November 26 2018

On November 16, 2018, the U.S. Department of Health and Human Services Office of Inspector General (“OIG”) issued Advisory Opinion No. 18-14

SBA Reports on Challenges Facing Small Businesses in Federal Procurement
  • Venable LLP
  • USA
  • October 31 2018

On October 11, 2018, the U.S. Small Business Administration (SBA) Office of Inspector General (OIG) published its Report on the Most Serious

FDA to implement OIG suggestions on IoT cybersecurity
  • Reed Smith LLP
  • USA
  • October 24 2018

The Office of the Inspector General (OIG) published a report in September 2018 after a review of the Food and Drug Administration’s (FDA) policies

Federal Health Fraud Penalties Are Rising Once Again
  • Reed Smith LLP
  • USA
  • October 11 2018

The Department of Health and Human Services (HHS) has just announced annual inflation-related increases to civil monetary penalties (CMPs) in its

Bundle of joy: OIG approves warranty program involving refund of aggregate purchase price of bundled product suite
  • Reed Smith LLP
  • USA
  • October 8 2018

The Office of Inspector General (OIG) recently approved a medical device manufacturer’s innovative proposed warranty program, under which the company

Reimbursement Issues Worth Noting: Administrative Law and False Claims Act Implications
  • Epstein Becker Green
  • USA
  • October 1 2018

News of two distantly related reimbursement issues with administrative law and False Claims Act (“FCA”) implications is worth noting. OIG Study Raises

Compliance Oversight and Program Integrity in Medicaid Managed Care
  • Manatt Phelps & Phillips LLP
  • USA
  • September 25 2018

In the past four months, the Government Accountability Office (GAO) and Office of the Inspector General (OIG) have issued a barrage of reports

HHS-OIG Work Plan - Medicare Advantage
  • Epstein Becker Green
  • USA
  • September 24 2018

Providers, plans, and vendors that provide services under the Medicare Advantage program, should be aware that the Office of Inspector General (“OIG”)

OIG Recommends FDA Use Pre-submission Program to Evaluate Cybersecurity Risks
  • Dinsmore & Shohl LLP
  • USA
  • September 20 2018

In September 2018 the OIG published its report on the FDA’s review practices for medical devices with cybersecurity implications, referred to as

OIG Advisory Opinion No. 18-08: Fire departments' mutual aid agreements
  • Krieg DeVault
  • USA
  • September 19 2018

On August 7, 2018, the Office of Inspector General (OIG) issued Advisory Opinion No. 18-08, which evaluated a proposal by six government-operated